价格

G-1

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PROCESS FOR THE MANUFACTURING OF (6AR,10AR)-7-PROPYL-6,6A,7,8,9,10,10A,11-OCTAHYDRO-[1,3]DIOXOLO[4',5':5,6]BENZO[1,2-G]QUINOLINE AND (4AR,10AR)-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDRO-BENZO[G]QUINOLINE-6,7-DIOL
US 2020369615 A1申请人: H LUNDBECK AS优先权: 2019
CN
EP
US
WO
11 件公开
SOLID FORMS OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID
US 2020392176 A1申请人: H LUNDBECK AS优先权: 2019
CN
EP
US
WO
10 件公开
Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US 11104697 B2申请人: H LUNDBECK AS优先权: 2019
CN
EP
US
WO
6 件公开
Polymers and compounds based on dipyrrolo[1,2-B:1',2'-G][2,6]naphthyridine-5,11-dione
US 10442888 B2申请人: BASF SE优先权: 2015
CN
EP
US
WO
5 件公开
1H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1H-PYRAZOLO[4,3-G]QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
EP 4126863 B1申请人: VERTEX PHARMA优先权: 2020
CN
EP
US
WO
5 件公开
EGFR INHIBITOR POLYMORPH FORMS
EP 4405360 A4申请人: ERASCA INC优先权: 2021
CN
EP
US
WO
5 件公开
Killer cell lectin-like receptor subfamily G member 1 (KLRG1) depleting antibodies
- US 11180561 B2
  申请人: ABCURO INC优先权: 2019
  CN
  US
  4 件公开
- EP 4377346 A1
  申请人: ABCURO INC优先权: 2021
  EP
  US
  2 件公开
Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US 11111263 B2申请人: H LUNDBECK AS优先权: 2019
CN
US
4 件公开
Oxidation dye composition for keratin fibers, comprising at least one oxidation dye, at least one associative polymer, at least one nonionic cellulose-based compound not comprising a C8-C30 fatty chain, and at least one cationic polymer with a charge density of greater than 1 meq/g and not comprising a C8-C30 fatty chain
US 7329287 B2申请人: OREAL优先权: 2003
US
4 件公开
BASE EDITING APPROACHES FOR CORRECTING THE IVS2-1 (G>A) MUTATION IN PATIENTS SUFFERING FROM BETA-THALASSEMIA
EP 4558633 A1申请人: INST NAT SANTE RECH MED优先权: 2022
EP
US
WO
3 件公开

药物

G-1

专利

Killer cell lectin-like receptor subfamily G member 1 (KLRG1) depleting antibodies